Indivior Pharmaceuticals (INDV) Change in Intangibles (2024 - 2025)
Indivior Pharmaceuticals (INDV) recorded quarterly Change in Intangibles of $1.0 million in Q2 2025, little changed quarter-over-quarter from $1.0 million in Q4 2024.
Indivior Pharmaceuticals (INDV) Change in Intangibles (2024 - 2025) Analysis & Trends
Indivior Pharmaceuticals' Change in Intangibles history runs 2 years deep, the most recent figure standing at $1.0 million for Q2 2025.
- In Q2 2025, Change in Intangibles changed N/A year-over-year to $1.0 million; the TTM figure through Dec 2025 stood at $1.0 million (down 50.0% YoY), while the FY2025 annual figure was $1.0 million, down 50.0% from the prior year.
- Change in Intangibles was $1.0 million for Q2 2025 at Indivior Pharmaceuticals, roughly flat from $1.0 million in the prior quarter.
- In the past five years, Change in Intangibles ranged from a high of $1.0 million in Q1 2024 to a low of $1.0 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Indivior Pharmaceuticals | - | - | 277.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 1.00 Mn |
| Jun 30, 2025 | 1.00 Mn |
| Dec 31, 2024 | 1.00 Mn |
| Dec 31, 2024 | 1.00 Mn |
| Mar 31, 2024 | 1.00 Mn |
| Mar 31, 2024 | 1.00 Mn |